ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      80.005
      0.00%
      Bitcoin
      104,741.69
      0.31%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Bausch plus Lomb Corporation (BLCO) Quote

      Bausch plus Lomb Corporation

      Bausch plus Lomb Corporation (BLCO)

      Bausch and Lomb Corporation
      Bausch and Lomb Corporation
      17.36
      -0.08
      (-0.46%)
      Closed January 19 4:00PM
      Delayed by 15 minutes
      17.27
      -0.09
      (-0.52%)
      After Hours: 6:22PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      17.27
      Bid
      -
      Ask
      -
      Volume
      711,230
      17.3216 Day's Range 17.57
      13.16 52 Week Range 21.69
      Market Cap
      6.082B
      Previous Close
      17.44
      Open
      17.47
      Last Trade
      25774
      @
      17.36
      Last Trade Time
      Financial Volume
      $ 12,429,057
      VWAP
      17.4754
      Average Volume (3m)
      455,093
      Shares Outstanding
      352,164,025
      Dividend Yield
      -
      PE Ratio
      -34.01
      Earnings Per Share (EPS)
      -0.74
      Revenue
      4.15B
      Net Profit
      -260M

      About Bausch plus Lomb Corporation

      Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a pu... Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. Show more

      Sector
      Offices Of Optometrists
      Industry
      Offices Of Optometrists
      Headquarters
      Toronto, Ontario, Can
      Founded
      -
      Bausch plus Lomb Corporation is listed in the Offices Of Optometrists sector of the New York Stock Exchange with ticker BLCO. The last closing price for Bausch plus Lomb was $17.44. Over the last year, Bausch plus Lomb shares have traded in a share price range of $ 13.16 to $ 21.69.

      Bausch plus Lomb currently has 352,164,025 shares outstanding. The market capitalization of Bausch plus Lomb is $6.14 billion. Bausch plus Lomb has a price to earnings ratio (PE ratio) of -34.01.

      Ask ADVFN Intelligence (AI)

      Bausch plus Lomb (BLCO) Options Flow Summary

      BLCO Options Flow

      Overall Flow

      Bearish

      Net Premium

      -319k

      Calls / Puts

      0.00%

      Buys / Sells

      150.00%

      OTM / ITM

      0.00%

      Sweeps Ratio

      0.00%

      BLCO Latest News

      More News

      Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced an affiliate has acquired Whitecap...

      January 13 2025
      Business Wire

      Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the enVista Aspire...

      January 13 2025
      Business Wire

      Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national nonprofit...

      January 07 2025
      Business Wire

      Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Chief...

      January 02 2025
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      December 26 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 26 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 26 2024
      Edgar (US Regulatory)

      Bausch + Lomb Responds to Rumors of a Potential Sale

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following statement in response to a request from...

      December 12 2024
      Business Wire

      Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that an affiliate has acquired Elios Vision...

      December 11 2024
      Business Wire

      Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE Recycling and...

      November 14 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.63-3.5195530726317.91816.75552704717.44258256CS
      4-0.68-3.7883008356517.9518.553416.75539953217.72847403CS
      12-2.91-14.420218037720.1820.9416.75545509318.9911656CS
      260.7254.3819885161716.54521.6914.0565194218.22347931CS
      522.3615.828303152214.9121.6913.1654271217.01548409CS
      156-1.23-6.6486486486518.521.9512.260634616.71075107CS
      260-1.23-6.6486486486518.521.9512.260634616.71075107CS

      BLCO - Frequently Asked Questions (FAQ)

      What is the current Bausch plus Lomb share price?
      The current share price of Bausch plus Lomb is $ 17.27
      How many Bausch plus Lomb shares are in issue?
      Bausch plus Lomb has 352,164,025 shares in issue
      What is the market cap of Bausch plus Lomb?
      The market capitalisation of Bausch plus Lomb is USD 6.14B
      What is the 1 year trading range for Bausch plus Lomb share price?
      Bausch plus Lomb has traded in the range of $ 13.16 to $ 21.69 during the past year
      What is the PE ratio of Bausch plus Lomb?
      The price to earnings ratio of Bausch plus Lomb is -34.01
      What is the cash to sales ratio of Bausch plus Lomb?
      The cash to sales ratio of Bausch plus Lomb is 2.13
      What is the reporting currency for Bausch plus Lomb?
      Bausch plus Lomb reports financial results in USD
      What is the latest annual turnover for Bausch plus Lomb?
      The latest annual turnover of Bausch plus Lomb is USD 4.15B
      What is the latest annual profit for Bausch plus Lomb?
      The latest annual profit of Bausch plus Lomb is USD -260M
      What is the registered address of Bausch plus Lomb?
      The registered address for Bausch plus Lomb is 520 APPLEWOOD CRESCENT, VAUGAN, ONTARIO, L4K 4B4, TORONTO, ONTARIO, L4K 4B4
      Which industry sector does Bausch plus Lomb operate in?
      Bausch plus Lomb operates in the OFFICES OF OPTOMETRISTS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ARLAmerican Realty Investors Inc
      $ 15.93
      (15.02%)
      		10.76k
      RBOTVicarious Surgical Inc
      $ 16.382
      (14.88%)
      		52.57k
      AUNAAuna SA
      $ 8.45
      (14.81%)
      		233.16k
      MYTEMYT Netherlands Parent BV
      $ 9.45
      (12.23%)
      		354.61k
      BKSYBlackSky Technology Inc
      $ 11.71
      (12.06%)
      		1.7M
      SESSES AI Corporation
      $ 0.9369
      (-9.91%)
      		51.58M
      DMDesktop Metal Inc
      $ 2.19
      (-9.88%)
      		547.32k
      JKSJinkosolar Holdings Co Ltd
      $ 21.23
      (-9.81%)
      		1.55M
      BODIBeachbody Company Inc
      $ 6.60
      (-9.59%)
      		19.82k
      QBTSD Wave Quantum Inc
      $ 5.275
      (-9.21%)
      		76.53M
      QBTSD Wave Quantum Inc
      $ 5.275
      (-9.21%)
      		76.53M
      FFord Motor Company
      $ 10.18
      (1.70%)
      		60.8M
      BBDBanco Bradesco SA
      $ 1.96
      (-1.01%)
      		59.92M
      VALEVale SA
      $ 8.94
      (1.94%)
      		59.4M
      SESSES AI Corporation
      $ 0.9369
      (-9.91%)
      		51.58M

      BLCO Discussion

      View Posts
      Zilla Zilla 1 month ago
      The end of 2024 is near but the spin/sale of BLCO is not. lol Well Blackstone might have gotten cold feet and invested elsewhere which is fine as the offer was probably too low. Maybe it gets settled around the 3 year IPO mark in May but who knows. Only 1.08 million short and 10.3% inst owned. Market cap of 6.53 billion @ 18.55 a share.
      BHC 7.65 and chart looking like a downer below the 20, 50 & 200 DMA's YIKES...
      👍️0
      Zilla Zilla 9 months ago
      Good ER but stock dived down, bounced up and down again...Hit 13.64 and closed 13.74
      So that golden cross might be off the table unless it pops tomorrow if BHC doesn't distribute in 2024...
      👍️0
      Zilla Zilla 9 months ago
      Almost another year later and 88.7% of BLCO is still with BHC almost 2 years after the IPO just before the ER...
      Currently BLCO is 14.79 with less than 5% short interest...10.5% Inst owned...
      BHC is @ 8.71 72% inst/owned about 12% short interest...
      Norwich lost in court recently and BHC had hit 11.46 a little before the verdict on a quick POP and it's been dropping ever since. Didn't break below the 200DMA of 8.30 but tested the 8.50's often...
      👍️0
      Zilla Zilla 9 months ago
      BLCO @ 14.79 with ER next week...
      200DMA 16.53
      50DMA 15.89
      Golden Cross may be heading our way...If the ER sends us up and BHC doesn't announce a distribution...
      👍️0
      Zilla Zilla 11 months ago
      Good ER and more than a buck higher open it looks like. I sold too soon as always and also I sold a 100 calls so that's about 20,000 I would have gotten more had I held 1 day longer. Still got my 'core' of calls that are good til there end of the year but these results are really good. Stock should be fine moving forward until BHC shareholders get the BLCO shares and then it will probably sell off but recover and make new highs at some point. =)
      👍️0
      Zilla Zilla 11 months ago
      Sold all 10,000 BLCO above 14.50 just a few cents higher than my cost after flipping so many times. Have good chunk of calls both ITM and not. Just felt I had WAY too much in one stock with all these M&A deals it seems like a 'top' is incoming. So as of now I'm about 20% in calls and 80% in cash... Was 15% cash and 85% invested this morning. Good luck tomorrow and the chart looks really good to run to 17's in the coming weeks as long as tomorrow doesn't surprise to the downside.
      👍️0
      Zilla Zilla 11 months ago
      Yesterday BLCO hit 14.66. I sold a good chunk @ 14.50 even though I wanted to keep it but got it back today @14
      Chart looking like a nice set up into and after earnings next week. We shall see but I've flipped enough times and lowered my average so I'm feeling good. If it tanks on news of BHC shareholders getting BLCO stock my BHC will rise/rocket and I can either hold that for the BLCO shares or trade them accordingly being I already have BLCO shares. Or buy the shares back into BHC and that works too. Stock too cheap down here under 15
      👍️0
      Zilla Zilla 12 months ago
      Today BLCO made new 52 week low of 13.85 currently at 14 with BHC at 8....Something has changed between these two stocks. lol
      I still think both are undervalued and stuck together. Needed to either give BHC shareholders the 80% BLCO shares or...Reverse Merge or buy back BLCO. At 14 for BLCO they could gobble it right back up and the spin at least let them pay down some debt when distressed the past year and a half.
      BLCO at 14 feels like a spin of the 50.1% is coming this year but who knows...ER's should be this month and hopefully BOTH stocks rise up to new 52 week highs but you never know. lol
      👍️0
      Zilla Zilla 2 years ago
      Today BLCO buys XIIDRA from NVS and makes new all time high of 21.95
      BHC went up to 8.22 and closed at 8
      So the future 'growth' will be the BLCO asset and getting 80% of the company in BHC shareholders hands. BHC is 7% short interest as BLCO is over 17 and stock is just above 20...
      I think both are undervalued
      👍️0
      Zilla Zilla 2 years ago
      1 year later not so much. lol Though 88.7% of BLCO is still with BHC over a year after the IPO...BS!
      Currently about 18.50 for BLCO with 19% short interest and almost 13% Inst/own...
      BHC I use to see under 10% short interest but I double taked when I saw 37.22% short interest (as of 5/31/23 and 66% Inst/own trading at 7.19 today. WTF?!? That's some SERIOUS Shorts...Also seems kind of fishy with the 5/17 judge ruling in BHC favor sending the stock from 6 to 9 in days...Only to have Norwich sue the FDA to overrule the courts news on 6/6/23 with the stock breaking below 8 the day before and then breaking below 7... I think a lawsuit and an investigation is in order.
      👍️0
      Zilla Zilla 3 years ago
      Well now we will see what B&L can do away from BHC/VRX
      👍️0
      weedtrader420 weedtrader420 3 years ago
      BLCO$ Cross Eyed Mary
      👍️0
      weedtrader420 weedtrader420 3 years ago
      BLCO$
      👍️0

      Your Recent History

      NYSE
      BLCO
      Bausch plus Lomb
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads